CTO stands for chronic total occlusion, a coronary artery that is completely blocked for three months or longer. Unlike a heart attack, where a sudden clot cuts off blood flow, a CTO develops gradually as plaque builds up until the artery is 100% sealed off. It’s one of the most challenging problems in interventional cardiology, found in roughly 15 to 25 percent of patients who undergo diagnostic heart catheterization.
How a CTO Differs From Other Blockages
Most coronary artery disease involves partial blockages that narrow blood flow but don’t stop it entirely. A CTO is different: zero blood gets through the blocked segment. Cardiologists distinguish between a “true” CTO, where flow is completely absent, and a “functional” CTO, where the artery is severely narrowed but a tiny trickle of blood still passes. Both must persist for at least three months to qualify as chronic rather than acute.
The three-month threshold matters because it changes both the biology and the treatment approach. Over time, the blockage hardens with calcium and fibrous tissue, making it far more difficult to reopen than a fresh clot. The longer a CTO has been in place, the tougher and more resistant to treatment it becomes.
Why Some People Have No Symptoms
One of the surprising things about CTOs is that the heart can partially compensate for a completely blocked artery. When an artery closes gradually, the pressure difference across the blockage stimulates tiny pre-existing blood vessels to enlarge and reroute blood around the obstruction. These detour vessels are called collaterals, and the process of their growth is driven by increased blood flow and physical stress on the vessel walls.
Over time, what starts as microscopic capillary connections can remodel into larger, muscular-walled arteries that resemble normal coronary vessels. This backup circulation can supply enough blood to keep heart muscle alive at rest. The trade-off is that collaterals rarely deliver enough blood during exercise or physical stress, which is why many people with a CTO feel fine sitting on the couch but develop chest pain or shortness of breath when they exert themselves. Some patients, particularly those with well-developed collateral networks, may have no symptoms at all and only discover the CTO incidentally during imaging for another reason.
How CTOs Are Diagnosed
CTOs are typically identified during a coronary angiogram, an imaging procedure where dye is injected into the coronary arteries and X-rays reveal the blockage in real time. The blocked segment shows up as an abrupt cutoff of dye flow. Cardiologists can also see whether collateral vessels have formed by watching dye travel through alternate routes to fill the artery beyond the blockage.
Before deciding whether to attempt reopening a CTO, doctors often assess whether the heart muscle downstream is still alive and capable of recovering function. This is called viability testing, and it uses imaging techniques like cardiac MRI or nuclear scans. On cardiac MRI, scarring that extends through less than 75% of the heart wall thickness in the affected area generally indicates enough living tissue to benefit from restored blood flow. If the muscle is mostly scar, reopening the artery won’t improve heart function.
Scoring Difficulty Before the Procedure
Not all CTOs are equally hard to fix. Cardiologists use a scoring system called the J-CTO score to predict how difficult a particular blockage will be to cross with a wire. It assigns one point for each of five features: a blunt, rounded entry point to the blockage (rather than a tapered one), heavy calcification, a bend greater than 45 degrees within the blocked segment, a blockage length of 20 millimeters or more, and a previous failed attempt to reopen it. A score of zero suggests a straightforward case. A score of four or five signals an extremely complex procedure.
How CTOs Are Treated
The procedure to reopen a CTO is a specialized form of percutaneous coronary intervention, commonly called PCI or angioplasty. A thin wire is threaded through the blockage, followed by a balloon and usually one or more stents to hold the artery open. It sounds straightforward, but CTO procedures are among the most technically demanding in cardiology and can take two to four hours, compared with under an hour for a typical angioplasty.
The standard first approach is called the antegrade technique, meaning the wire enters the blockage from the normal direction of blood flow. Within this category, operators may escalate through progressively stiffer wires or use a technique where the wire intentionally travels through the vessel wall around the blockage and then re-enters the true channel beyond it. Antegrade procedures generally involve shorter times and fewer complications.
When the antegrade approach fails, or when the anatomy is particularly complex, cardiologists can attempt a retrograde approach. This involves threading a wire backward through collateral vessels from a neighboring artery, crossing the blockage from the far side. It’s a more demanding technique that carries higher risks, including a greater chance of heart muscle injury from temporarily blocking collateral flow. Retrograde procedures are typically reserved for the most difficult cases or as a rescue strategy after an antegrade attempt doesn’t succeed.
Success Rates and Risks
Outcomes depend heavily on who performs the procedure. In a UK registry, dedicated CTO operators achieved a success rate of about 90%, while general interventional cardiologists succeeded roughly 50% of the time. This gap highlights why CTO procedures are increasingly concentrated at specialized centers with high-volume operators.
The most significant procedural risk is coronary perforation, where the wire or equipment punctures through the artery wall. This occurs in about 3.8% of CTO procedures overall, but the risk varies widely based on patient and lesion characteristics. For a straightforward case, perforation risk can be under 1%. For an elderly patient with a heavily calcified blockage requiring a retrograde approach, the risk can exceed 9%. When perforations do occur, the rate of major complications like emergency surgery or heart attack rises substantially.
Recovery and Quality of Life After CTO Treatment
For patients whose procedures succeed, the improvements can be meaningful. Studies measuring quality of life show significant reductions in shortness of breath and angina within one month of a successful CTO procedure, with benefits sustained at one year for most patients. Overall quality-of-life scores improve regardless of other health conditions, and patients report being able to do more physical activity with less discomfort.
Successful CTO procedures have also been linked to improved heart pumping function and, in some studies, better long-term survival. The symptom relief tends to be most durable in patients with otherwise healthy kidneys. In patients with severely reduced kidney function, initial symptom improvements at one month sometimes diminish by the one-year mark, though overall quality of life still tends to be better than before the procedure.
Medical Therapy as an Alternative
Not every CTO needs to be reopened. If the heart muscle beyond the blockage is mostly scar tissue, or if collateral circulation is providing adequate blood flow, the risks of a complex procedure may outweigh the benefits. In these cases, treatment focuses on medications to manage chest pain, control cholesterol and blood pressure, and reduce the risk of future cardiovascular events. The decision between attempting to reopen a CTO and managing it with medication alone depends on the severity of symptoms, the amount of viable heart muscle at stake, the technical difficulty of the blockage, and the patient’s overall health.